Therapeutic advances in musculoskeletal disease

Keyphrases

Publications

volume 16, 2024

Or Hen, Stephanie R Harrison, Gabriele de Marco, Helena Marzo-Ortega
Early psoriatic arthritis: when is the right time to start advanced therapy? Therapeutic advances in musculoskeletal disease 16 (2024)
Angelo Fassio, Davide Gatti, Annalisa Biffi, Raffaella Ronco, Gloria Porcu, Giovanni Adami, Rosaria Alvaro, Riccardo Bogini, Achille P Caputi, Luisella Cianferotti, Bruno Frediani, Stefano Gonnelli, Giovanni Iolascon, Andrea Lenzi, Salvatore Leone, Raffaella Michieli, Silvia Migliaccio, Tiziana Nicoletti, Marco Paoletta, Annalisa Pennini, Eleonora Piccirilli, Maurizio Rossini, Maria Luisa Brandi, Giovanni Corrao, Umberto Tarantino
The sequential antifracturative treatment: a meta-analysis of randomized clinical trials. Therapeutic advances in musculoskeletal disease 16 (2024)
Yu-Ping Chen, Wing P Chan, Han-Wei Zhang, Zhi-Ren Tsai, Hsiao-Ching Peng, Shu-Wei Huang, Yeu-Chai Jang, Yi-Jie Kuo
Automated osteoporosis classification and T -score prediction using hip radiographs via deep learning algorithm. Therapeutic advances in musculoskeletal disease 16 (2024)
Kuniaki Ota, Yuta Asanuma, Hideyuki Hirasawa, Hiroaki Ohta, Toshifumi Takahashi
Minodronate for severe multiple vertebral fractures due to pregnancy- and lactation-associated osteoporosis: a case report and literature review. Therapeutic advances in musculoskeletal disease 16 (2024)
Anne Grethe Jurik, Nele Herregods
The sacroiliac joint across ages - what is normal? Therapeutic advances in musculoskeletal disease 16 (2024)
Wei Liu, Chunyan Li, Wen-Hui Xie, Yong Fan, Xiaohui Zhang, Yu Wang, Lei Li, Zhuoli Zhang
The signature of the gut microbiota associated with psoriatic arthritis revealed by metagenomics. Therapeutic advances in musculoskeletal disease 16 (2024)
Merel Hartog, Kyra A L van Keeken, Cornelia H M van den Ende, Calin D Popa
Intramuscular methylprednisolone administration in hand osteoarthritis patients: a feasibility study to inform a randomized controlled trial. Therapeutic advances in musculoskeletal disease 16 (2024)
Antimo Moretti, Francesco Snichelotto, Sara Liguori, Marco Paoletta, Giuseppe Toro, Francesca Gimigliano, Giovanni Iolascon
The challenge of pharmacotherapy for musculoskeletal pain: an overview of unmet needs. Therapeutic advances in musculoskeletal disease 16 (2024)
Maria Consiglia Trotta, Annalisa Itro, Caterina Claudia Lepre, Marina Russo, Francesca Guida, Antimo Moretti, Adriano Braile, Umberto Tarantino, Michele D'Amico, Giuseppe Toro
Effects of adipose-derived mesenchymal stem cell conditioned medium on human tenocytes exposed to high glucose. Therapeutic advances in musculoskeletal disease 16 (2024)
Angelo Fassio, Davide Gatti, Annalisa Biffi, Raffaella Ronco, Gloria Porcu, Giovanni Adami, Rosaria Alvaro, Riccardo Bogini, Achille P Caputi, Luisella Cianferotti, Bruno Frediani, Stefano Gonnelli, Giovanni Iolascon, Andrea Lenzi, Salvatore Leone, Raffaella Michieli, Silvia Migliaccio, Tiziana Nicoletti, Marco Paoletta, Annalisa Pennini, Eleonora Piccirilli, Maurizio Rossini, Maria Luisa Brandi, Giovanni Corrao, Umberto Tarantino
The sequential antifracturative treatment: a meta-analysis of randomized clinical trials. Therapeutic advances in musculoskeletal disease 16 (2024)
Felipe Araya-Quintanilla, Robinson Ramirez-Vélez, Guillermo Mendez-Rebolledo, Iván Cuyul-Vásquez, Alexis Arce-Álvarez, Yasmin Ezzatvar, Hector Gutierrez-Espinoza
Effects of acupuncture versus placebo on clinical status and potential specific effects in Fibromyalgia: an umbrella review of 11 meta-analyses. Therapeutic advances in musculoskeletal disease 16 (2024)
David Kiefer, Lucia Schneider, Jüergen Braun, Uta Kiltz, Niklas Kolle, Ioana Andreica, Styliani Tsiami, Bjoern Buehring, Philipp Sewerin, Susanne Herbold, Xenofon Baraliakos
Impact of daily physical therapy over 2 weeks on spinal mobility including objective electronic measurements and function in patients with axial spondyloarthritis. Therapeutic advances in musculoskeletal disease 16 (2024)
Jacob Corum Williams, Ryan Malcolm Hum, Kira Rogers, Cristina Maglio, Uazman Alam, Sizheng Steven Zhao
Metabolic syndrome and psoriatic arthritis: the role of weight loss as a disease-modifying therapy. Therapeutic advances in musculoskeletal disease 16 (2024)
Wei Liu, Chunyan Li, Wen-Hui Xie, Yong Fan, Xiaohui Zhang, Yu Wang, Lei Li, Zhuoli Zhang
The signature of the gut microbiota associated with psoriatic arthritis revealed by metagenomics. Therapeutic advances in musculoskeletal disease 16 (2024)
Shaoling Yang, Xiaojing Lin, Yining Gao, Nan Liang, Yali Han, Hang Sun, Shen Qu, Haibing Chen
The association between gout flares and monosodium urate burden assessed using musculoskeletal ultrasound in patients with gout. Therapeutic advances in musculoskeletal disease 16 (2024)
Marion E E Watson, William Tillett, Deepak Jadon, M Sofia Massa, E Anne Francis, Nicola Gullick, Ines Rombach, Yvonne Sinomati, Laura Tucker, Laura C Coates
The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomized controlled trial. Therapeutic advances in musculoskeletal disease 16 (2024)
Marion E E Watson, William Tillett, Deepak Jadon, M Sofia Massa, E Anne Francis, Nicola Gullick, Ines Rombach, Yvonne Sinomati, Laura Tucker, Laura C Coates
The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomized controlled trial. Therapeutic advances in musculoskeletal disease 16 (2024)
Jasper F Nies, Claudia Hendrix, Malte P Bartram, Ryan Spear, Henning Hagmann, Thomas Benzing, Torsten Kubacki
Effectiveness and safety of immunoadsorption as a rescue treatment of inflammatory myopathies: report of three cases and literature review. Therapeutic advances in musculoskeletal disease 16 (2024)
Uta Kiltz, Xenofon Baraliakos, Jan Brandt-Jürgens, Ulf Wagner, Sebastian Lieb, Christian Sieder, Christian Mann, Jüergen Braun
Efficacy and NSAID-sparing effect of secukinumab 150 mg in ankylosing spondylitis: results from phase IV ASTRUM study. Therapeutic advances in musculoskeletal disease 16 (2024)
Anne Grethe Jurik, Nele Herregods
The sacroiliac joint across ages - what is normal? Therapeutic advances in musculoskeletal disease 16 (2024)
Angela M Mickle, Roland Staud, Cynthia S Garvan, Daniel A Kusko, Nicola Sambuco, Brittany R Addison, Kevin R Vincent, David T Redden, Burel R Goodin, Roger B Fillingim, Kimberly T Sibille
Dispositional traits help explain individual differences in relationships between a radiographic knee osteoarthritis measure, pain, and physical function. Therapeutic advances in musculoskeletal disease 16 (2024)
Shaoling Yang, Xiaojing Lin, Yining Gao, Nan Liang, Yali Han, Hang Sun, Shen Qu, Haibing Chen
The association between gout flares and monosodium urate burden assessed using musculoskeletal ultrasound in patients with gout. Therapeutic advances in musculoskeletal disease 16 (2024)
Desirée Ruiz-Vilchez, María Lourdes Ladehesa-Pineda, María Ángeles Puche-Larrubia, María Carmen Ábalos-Aguilera, Pilar Font-Ugalde, Alejandro Escudero-Contreras, Eduardo Collantes-Estévez, Clementina López Medina
The socioeconomic status of patients with ankylosing spondylitis and its association with the burden of the disease and permanent disability: a cross-sectional cluster analysis. Therapeutic advances in musculoskeletal disease 16 (2024)
Delphine Bertrand, Anke Deprez, Michaël Doumen, Diederik De Cock, Sofia Pazmino, Anja Marchal, Marc Thelissen, Johan Joly, Elias De Meyst, Barbara Neerinckx, René Westhovens, Patrick Verschueren
To flare or not to flare: patients' and rheumatologists' perceptions on the on-flare retreatment strategy of rituximab in rheumatoid arthritis. Therapeutic advances in musculoskeletal disease 16 (2024)
Delphine Bertrand, Anke Deprez, Michaël Doumen, Diederik De Cock, Sofia Pazmino, Anja Marchal, Marc Thelissen, Johan Joly, Elias De Meyst, Barbara Neerinckx, René Westhovens, Patrick Verschueren
To flare or not to flare: patients' and rheumatologists' perceptions on the on-flare retreatment strategy of rituximab in rheumatoid arthritis. Therapeutic advances in musculoskeletal disease 16 (2024)
Felipe Araya-Quintanilla, Robinson Ramirez-Vélez, Guillermo Mendez-Rebolledo, Iván Cuyul-Vásquez, Alexis Arce-Álvarez, Yasmin Ezzatvar, Hector Gutierrez-Espinoza
Effects of acupuncture versus placebo on clinical status and potential specific effects in Fibromyalgia: an umbrella review of 11 meta-analyses. Therapeutic advances in musculoskeletal disease 16 (2024)
Maria Consiglia Trotta, Annalisa Itro, Caterina Claudia Lepre, Marina Russo, Francesca Guida, Antimo Moretti, Adriano Braile, Umberto Tarantino, Michele D'Amico, Giuseppe Toro
Effects of adipose-derived mesenchymal stem cell conditioned medium on human tenocytes exposed to high glucose. Therapeutic advances in musculoskeletal disease 16 (2024)
Dalifer Freites-Nuñez, Leticia Leon, Esther Toledano, Gloria Candelas, Cristina Martinez, Maria Rodriguez-Laguna, Daniel Rubio, Benjamín Fernández Gutiérrez, Lydia Abasolo
Switching related to inefficacy in biologics and targeted synthetic therapies for psoriatic arthritis: a comparative real-life study. Therapeutic advances in musculoskeletal disease 16 (2024)
Jacob Corum Williams, Ryan Malcolm Hum, Kira Rogers, Cristina Maglio, Uazman Alam, Sizheng Steven Zhao
Metabolic syndrome and psoriatic arthritis: the role of weight loss as a disease-modifying therapy. Therapeutic advances in musculoskeletal disease 16 (2024)
Dalifer Freites-Nuñez, Leticia Leon, Esther Toledano, Gloria Candelas, Cristina Martinez, Maria Rodriguez-Laguna, Daniel Rubio, Benjamín Fernández Gutiérrez, Lydia Abasolo
Switching related to inefficacy in biologics and targeted synthetic therapies for psoriatic arthritis: a comparative real-life study. Therapeutic advances in musculoskeletal disease 16 (2024)
Kuniaki Ota, Yuta Asanuma, Hideyuki Hirasawa, Hiroaki Ohta, Toshifumi Takahashi
Minodronate for severe multiple vertebral fractures due to pregnancy- and lactation-associated osteoporosis: a case report and literature review. Therapeutic advances in musculoskeletal disease 16 (2024)
Delphine Bertrand, Anke Deprez, Michaël Doumen, Diederik De Cock, Sofia Pazmino, Anja Marchal, Marc Thelissen, Johan Joly, Elias De Meyst, Barbara Neerinckx, René Westhovens, Patrick Verschueren
To flare or not to flare: patients' and rheumatologists' perceptions on the on-flare retreatment strategy of rituximab in rheumatoid arthritis. Therapeutic advances in musculoskeletal disease 16 (2024)
Or Hen, Stephanie R Harrison, Gabriele de Marco, Helena Marzo-Ortega
Early psoriatic arthritis: when is the right time to start advanced therapy? Therapeutic advances in musculoskeletal disease 16 (2024)
Jing Wu, Yongying Liang, Fanjun Shi, Xianghong Tu, Jingfa Zhang, Qinghua Qiu
Meibomian gland dropout of upper eyelids as a novel biomarker for early diagnosis of primary Sjögren's syndrome: a pilot study. Therapeutic advances in musculoskeletal disease 16 (2024)
Wolfgang Andreas Schmidt, Valentin Sebastian Schäfer
Diagnosing vasculitis with ultrasound: findings and pitfalls. Therapeutic advances in musculoskeletal disease 16 (2024)
Uta Kiltz, Xenofon Baraliakos, Jan Brandt-Jürgens, Ulf Wagner, Sebastian Lieb, Christian Sieder, Christian Mann, Jüergen Braun
Efficacy and NSAID-sparing effect of secukinumab 150 mg in ankylosing spondylitis: results from phase IV ASTRUM study. Therapeutic advances in musculoskeletal disease 16 (2024)
Merel Hartog, Kyra A L van Keeken, Cornelia H M van den Ende, Calin D Popa
Intramuscular methylprednisolone administration in hand osteoarthritis patients: a feasibility study to inform a randomized controlled trial. Therapeutic advances in musculoskeletal disease 16 (2024)
Wolfgang Andreas Schmidt, Valentin Sebastian Schäfer
Diagnosing vasculitis with ultrasound: findings and pitfalls. Therapeutic advances in musculoskeletal disease 16 (2024)
Jasper F Nies, Claudia Hendrix, Malte P Bartram, Ryan Spear, Henning Hagmann, Thomas Benzing, Torsten Kubacki
Effectiveness and safety of immunoadsorption as a rescue treatment of inflammatory myopathies: report of three cases and literature review. Therapeutic advances in musculoskeletal disease 16 (2024)
Antimo Moretti, Francesco Snichelotto, Sara Liguori, Marco Paoletta, Giuseppe Toro, Francesca Gimigliano, Giovanni Iolascon
The challenge of pharmacotherapy for musculoskeletal pain: an overview of unmet needs. Therapeutic advances in musculoskeletal disease 16 (2024)
Yu-Ping Chen, Wing P Chan, Han-Wei Zhang, Zhi-Ren Tsai, Hsiao-Ching Peng, Shu-Wei Huang, Yeu-Chai Jang, Yi-Jie Kuo
Automated osteoporosis classification and T -score prediction using hip radiographs via deep learning algorithm. Therapeutic advances in musculoskeletal disease 16 (2024)
Jing Wu, Yongying Liang, Fanjun Shi, Xianghong Tu, Jingfa Zhang, Qinghua Qiu
Meibomian gland dropout of upper eyelids as a novel biomarker for early diagnosis of primary Sjögren's syndrome: a pilot study. Therapeutic advances in musculoskeletal disease 16 (2024)
Hong-Ki Min, Se Hee Kim, Sang-Heon Lee, Hae-Rim Kim, Sang-Hoon Lee
Costotransverse joint ankylosis and their association with syndesmophyte progression in patients with radiographic axial spondyloarthritis. Therapeutic advances in musculoskeletal disease 16 (2024)
Hong-Ki Min, Se Hee Kim, Sang-Heon Lee, Hae-Rim Kim, Sang-Hoon Lee
Costotransverse joint ankylosis and their association with syndesmophyte progression in patients with radiographic axial spondyloarthritis. Therapeutic advances in musculoskeletal disease 16 (2024)
Elpida Skouvaklidou, Paraskevi Avgerou, Konstantinos D Vassilakis, George E Fragoulis, Nikolaos Kougkas
Monotherapy or combination therapy in PsA: current aspects. Therapeutic advances in musculoskeletal disease 16 (2024)
Mrinalini Dey, Elena Nikiphorou
Cardiovascular comorbidities in psoriatic arthritis: state of the art. Therapeutic advances in musculoskeletal disease 16 (2024)
Michael J Langworthy, Vinod Dasa, Andrew I Spitzer
Knee osteoarthritis: disease burden, available treatments, and emerging options. Therapeutic advances in musculoskeletal disease 16 (2024)
Delphine Bertrand, Anke Deprez, Michaël Doumen, Diederik De Cock, Sofia Pazmino, Anja Marchal, Marc Thelissen, Johan Joly, Elias De Meyst, Barbara Neerinckx, René Westhovens, Patrick Verschueren
To flare or not to flare: patients' and rheumatologists' perceptions on the on-flare retreatment strategy of rituximab in rheumatoid arthritis. Therapeutic advances in musculoskeletal disease 16 (2024)
Angela M Mickle, Roland Staud, Cynthia S Garvan, Daniel A Kusko, Nicola Sambuco, Brittany R Addison, Kevin R Vincent, David T Redden, Burel R Goodin, Roger B Fillingim, Kimberly T Sibille
Dispositional traits help explain individual differences in relationships between a radiographic knee osteoarthritis measure, pain, and physical function. Therapeutic advances in musculoskeletal disease 16 (2024)
David Kiefer, Lucia Schneider, Jüergen Braun, Uta Kiltz, Niklas Kolle, Ioana Andreica, Styliani Tsiami, Bjoern Buehring, Philipp Sewerin, Susanne Herbold, Xenofon Baraliakos
Impact of daily physical therapy over 2 weeks on spinal mobility including objective electronic measurements and function in patients with axial spondyloarthritis. Therapeutic advances in musculoskeletal disease 16 (2024)